He represents public and private companies primarily in the technology, life sciences and healthcare industries as well as investment firms that serve these sectors.

He brings to clients his extensive background representing issuers, underwriters and venture capital firms regarding both public and private offerings. Andrew is highly experienced in securities law compliance and corporate governance matters. Andrew's transactional experience includes IPOs, PIPEs, registered direct offerings and direct follow-on offerings, as well as venture capital, private equity, M&A and other strategic transactions. He also has counseled numerous entrepreneurs and emerging growth companies in planning profitable liquidity strategies. Andrew regularly serves as outside general counsel for private and public companies at various stages of development. Andrew is a member of the firm's National Leadership Group of the US Emerging Growth and Venture Capital practice.